sec filing
LI
NASDAQ · LIMN
Liminatus Pharma, Inc. Class A Common Stock
Healthcare · Biotechnology
$2.79
Up+$0.00 (+0.16%)
Updated Nov 5, 2026, 4:08 AM
SID Score
5.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 23.41M
- P/E ratio
- -9.06
- Dividend yield
- 0.00%
- 52-week range
- $0.10 – $7.48
- Volume
- 34.65K
- Avg. volume
- 630.53K
Price performance · LIMN
LIMN price history
1M range · 0 trading sessions · Daily adjusted prices
LIMN does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest LIMN news
The latest Smart Investors Daily articles mentioning LIMN.
Stock researchCompany · Financials
Company
Market Activity
Research & News
Loading stock research…